A Korean cosmetics sourcing agent converts your brief into a manufacturable specification, matches it to a factory, runs the sample rounds, holds the specification steady through first production, schedules testing, and assembles the export paperwork. Six jobs, sold as one. What the agent does not take on matters just as much.
The usual definition, the party standing between a brand and its factories, is accurate and useless. It says nothing about what the role involves on a Tuesday in month three, when a sample has come back too thick, the cap supplier has quoted a lead time that does not fit the launch, and someone has to decide which problem gets solved first. This article is about that work: a sourcing agent's scope of work, what it does not include, and which parts of a project stay yours no matter who you hire. It is not about how to tell a good agent from a bad one; that is a separate question with its own checklist, covered in how to vet a Korean cosmetics supplier before committing.
The Work, Stage by Stage
Here they are in the order a project meets them.
Translating a brief into a manufacturable specification. Brands arrive with a reference product, a mood board, a price target and a launch date. None of those are instructions a factory can act on. Someone has to convert them into a specification: format, viscosity, fragrance load, active positioning, container type, fill volume, decoration method. More importantly, someone has to notice where the brief contradicts itself. A texture that light and a claim that strong and a cost that low is frequently three requirements you can have two of. Finding that out in week two costs a conversation. Finding it out after tooling costs a season.
Matching the project to the right factory. No Korean facility is excellent at everything. The plant that produces a genuinely good sunscreen is rarely the one you want filling sheet masks, and the one that runs beautiful small batches of serum may have no interest in a body wash volume. Matching is the part of the job that is invisible when done well and expensive when done badly, because a formula placed in a facility that tolerates rather than wants the category will be technically fine and quietly deprioritised for two years.
Running the sample rounds. A development cycle is not one sample, it is a sequence of them, each with written feedback specific enough to act on. "Too sticky" is not feedback. "Tack persists past 90 seconds on application; reduce it without losing the cushion in the first 20" is. Someone has to write that, in Korean, to a formulator who has forty other projects.
Holding the specification steady. Between approved sample and first production there is a period where small substitutions happen for entirely reasonable reasons — a raw material lot changes, a component goes out of stock, a decoration method turns out not to hold on that surface. Each individual change is defensible. The cumulative drift is how brands end up with a first production run that does not match the sample they signed off. Preventing that is a specific, unglamorous, continuous task.
Quality and testing coordination. Stability, compatibility, challenge testing and whatever your destination market requires have to be scheduled before production, not discovered after it. This is where a project either has slack in the timeline or does not. Our quality control and testing process exists because this stage is where many launch delays are created, months before they become visible.
Documentation and handover. Export paperwork, ingredient disclosures, certificates, artwork approvals, shipping marks. Individually trivial; collectively the reason a shipment sits in a port. Each destination market requires its own set of paperwork, and the set is not negotiable; that is the work export and regulatory support covers.
What Stays Yours
This is the part most worth being precise about before you sign anything, because it is easy to discover the answer late.
The formula, if the contract says so. Custom development produces intellectual property, and who owns it is decided by contract rather than by fairness. A formula developed to your brief, at your cost, can still belong to the lab that wrote it, and can then legally appear in a competitor's product next season. If exclusivity matters to you, it has to be written, with a defined scope — exclusive in which categories, in which markets, for how long. The distinction between developing your own formula and licensing a house one is worth understanding on its own terms, and the trade-offs between private label and a custom formula set out what you gain and give up in each direction.
The factory relationship, or not. Some agreements are explicitly structured so that the brand never learns which facility makes its product. That is not automatically bad faith; it is the commercial protection of an intermediary whose value is the network. Non-disclosure written plainly into the agreement is different from dodging the question when you ask it; the second is the warning sign. But it does mean that if the relationship ends, the product does not travel with you. Decide which of those two things you are buying: a managed outcome, or a supply chain you can eventually run yourself. Then price the agreement accordingly.
Regulatory responsibility. An agent can prepare, compile and submit. In almost every market the legal responsibility still lands on the entity whose name is on the label or on the importer of record. A Responsible Person in the EU, the responsible person named on the label under MoCRA in the US, and whatever local role each of your other markets defines: these are positions someone must occupy, and "our agent handles it" is not a position. Check what your market requires and who is formally standing in that role.
Is It an Agent, a Trading Company, or an ODM Partner?
Ask who will invoice you for the goods, and the agent separates from the other two at once: with an agent the factory invoices you, while a trading company and an ODM partner invoice you themselves. Then ask who develops the product, and the remaining two separate as well. They answer the same enquiry and describe themselves in nearly the same words, but the money moves differently in each.
A sourcing agent in the strict sense works on your behalf and is paid by you. The goods are bought by you, invoiced to you, and the agent's fee is separate from the cost of the goods. That separation puts their incentives closer to yours than a reseller's. How close depends on how the fee is set: a retainer or a project fee does not move with the factory price, but a commission on goods value still rises with it.
A trading company buys and resells. You are its customer, the factory is its supplier, and its margin lives in the difference between the two prices. This is a perfectly legitimate model, and it is how much of world trade runs. But it is not agency, and the incentives are different in a specific way: your saving is its loss.
An ODM partner develops the product and takes responsibility for producing it, starting from its own formulation library or writing a new one. Development and the production commitment sit with the same party, whether it runs the lines itself or places production with factories it works with, which is why ODM development in Korea behaves differently from either of the models above. The differences between OEM, ODM and private label are worth reading before you decide which of the three you want, because the words are used loosely across the industry and the differences are contractual rather than cosmetic.
None of these is the right answer in general. The mistake is assuming you know which one you are speaking to.
What Belongs in the Agreement
Six things, and their absence is more informative than their contents.
Scope, listed as tasks. Not "sourcing support" but the specific stages above, marked in or out. Whether factory audits are included. Whether pre-shipment inspection is included. Whether artwork management is included. Anything left vague here becomes a negotiation later, after you have already paid.
How the agent is paid, and by whom. Commission on goods value, flat retainer, per-project fee, or margin inside the price — each creates a different incentive, and the model determines what the agent is quietly optimising for. This one deserves its own treatment, and it has one: how sourcing agent fees are actually structured.
Formula ownership and exclusivity. As above, in writing, with scope and duration.
Who signs off production. The moment a batch is released is the moment you accept it. Name the person and the document.
What happens on exit. Whether you keep the formula, the artwork files, the component tooling, the supplier list. Tooling in particular is frequently paid for by the brand and held by someone else.
Confidentiality in both directions. Your brief and launch plan are commercially sensitive before launch, and the obligation should be mutual and dated.
Do You Need a Sourcing Agent at All?
Not if three things are true: you have formulation judgement in-house, you have regulatory capability for your destination markets, and your volumes are large enough that factories want the work. Then intermediation is cost without function, and you should go direct.
Most first-time brands have none of the three, and the coordination work does not disappear when nobody is hired to do it. It falls to the founder, after hours, in a language they do not read. The useful question is who does the coordination, whether they are good at it, and whether you are paying for it visibly or invisibly.
If you would rather ask than read further, tell us about your project and we will tell you which of these stages your brief needs.
Frequently Asked Questions
Is a sourcing agent the same as a trading company?
No, and the difference is structural rather than semantic. An agent acts on your behalf and is paid by you, with the goods invoiced to you by the factory. A trading company buys the goods and resells them to you, taking its margin between the two prices.
Both are legitimate. Ask which one you are dealing with by asking who will invoice you for the goods. The answer is definitive and nobody minds the question.
Who owns the formula if a sourcing agent had it developed?
Whoever the contract says, which is frequently not the brand. Custom development paid for by you does not automatically transfer ownership of the resulting formula, and without an exclusivity clause the same formula can appear elsewhere. Settle this before development starts rather than after, because the negotiating position is entirely different once the samples are approved.
Can we keep working with the factory if we stop using the agent?
Only if the agreement allows it, and many are written specifically to prevent it. Some agents will not disclose the manufacturer at all.
If the ability to eventually go direct matters to you, it has to be negotiated at the start. It is a commercial term, not a courtesy, and asking for it later reads as a threat rather than a request.
Do we still need our own regulatory Responsible Person?
In most markets, yes. An agent can compile and submit documentation, but the legal role is occupied by a named entity, and it is usually you or your importer.
An EU Responsible Person, the responsible person named on a US label under MoCRA, and whatever local role your other markets define: confirm who is formally standing in that position for each market before you ship, not after a customs query.
How much of this can a small beauty brand do itself?
More than people expect on the specification side, less than they expect on the factory-matching and Korean-language side. Founders who have made a product before can write a usable brief.
What is hard to replicate from outside is knowing which Korean facilities are genuinely good at your category this year, and getting a formulator to prioritise a small project among larger ones.
